Interstitial deletion of 6q21-22 has been previously reported in 11 individuals, who presented with intellectual disability, facial dysmorphism, cardiac abnormality, cerebellar hypoplasia and dysplasia of the corpus callosum. Here, we report the first instance of a patient with 6q21-22 deletion presenting with interrupted aortic arch in addition to the previously described clinical signs. Array analysis using Agilent Human genome CGH 180K identified a 13.3-Mb deletion at 6q21-q22.31 (nt. 109885195-123209593 Common clinical features of 6q21-22 deletion among 11 previously reported patients 1-4 and our current patient include intellectual disability, hyper-or hypotelorism, long philtrum or wide nasal bridge, microcephaly and dysplasia of the corpus callosum and cerebellum. Cardiac abnormalities were also detected in 5 of these 12 patients, including ventricular septal defect (VSD), pulmonary atresia, coarctation of aorta (CoA), double outlet right ventricle and patent ductus arteriosus. Interrupted aortic arch (IAA) type B was identified only in our patient (Table 1) .
(Agilent Technologies, Santa Clara, CA, USA) and a 13.3-Mb deletion at 6q21-q22.31 (nt. 109885195-123209593) was detected.
Concerning cardiac abnormalities in 6q21-22 deletion syndrome, all patients shared the deleted region from 113 to 114.5 Mb including the myristoylated alanine-rich protein kinase c substrate (MARCKS) and histone deacetylase 2 (HDAC2) genes, among others ( Figure 1e ). MARCKS is an actin and calmodulinbinding protein, and MARCKS-null mice experience embryonic lethality because of a neural defect. 5 No cardiac phenotype has been reported in MARKS-null mice, although MARCKS is expressed in the endothelial cells where it regulates migration. 6 HDAC2 regulates cardiac morphogenesis and growth with uncontrolled proliferation of ventricular cardiomyocytes, obliteration of the right ventricle and perinatal lethality occurring in HDAC2-null mice. Abnormal HDAC2 expression is associated with hypoplastic right heart syndrome, right ventricular dysplasia and transposition of the great arteries. 7 The DECIPHER database describes Patient 2,498, who harbors a deletion within 6q21-22.1 (nt. 11321360-115432628). This region includes MARCKS and HDAC2. Abnormalities of the vascular system are described for Patient 2,498; however, detailed information was not available.
The patient presenting with CoA reported by Bzduch et al. 1 was examined using G-banding, but not aCGH, and so the exact position of the deletion was not defined . However, both the CoA patient and our current patient shared deletion of 6q22.2 to 12.3 Mb and this region includes gap junction protein alpha-1 (GJA1). GJA1 knockout mice die in utero because of swelling and blockage of the right ventricular outflow track from the heart. However, IAA was not reported. 8 We report a patient with 6q21-22 deletion presenting with IAA. Previous patient reports and knockout mouse analyses indicate that 6q21-22 deletion leads to right cardiac anomalies. Our findings and those reported by Bzduch et al. 1 suggest that IAA/CoA is also a possible phenotype of 6q21-22 deletion. Understanding the genotype-phenotype relationship and identification of the gene deletion(s) responsible for IAA/CoA will require study of additional patients with 6q21-22 deletion. 
